Medicare Advantage’s Impact on Seniors with Type 2 Diabetes Questioned by Study

Study Findings on Medicare Advantage and Health Outcomes

A recent study in JAMA Internal Medicine questions the effectiveness of Medicare Advantage plans in improving health outcomes for seniors with Type 2 diabetes. Despite offering extras like grocery allowances, dental coverage, and gym memberships, the study found these plans did not lead to better health results compared to traditional Medicare.

The research highlights that older adults with Type 2 diabetes enrolling in Medicare Advantage saw no significant improvements in health indicators such as hemoglobin A1C, LDL cholesterol, and blood pressure.

Medicare Advantage’s Growing Role

Medicare Advantage covers a majority of Medicare beneficiaries, accounting for around 55 percent, and is marketed as a cost-effective alternative to traditional Medicare, often including extra benefits. However, the findings may contribute to debates in Washington over the value and federal spending on Medicare Advantage.

Study Details

Tracking about 35,000 adults over 3.5 years, the study examined whether switching to Medicare Advantage improved diabetes management. Researchers found that 45 percent of participants in Medicare Advantage did not see better outcomes compared to those in traditional Medicare.

Michael Ryan, a finance expert, noted that despite higher spending on Medicare Advantage, no corresponding improvement in health outcomes was found. The authors suggest supplemental benefits may not effectively reach beneficiaries.

Seth Berkowitz, the lead researcher, indicated that while benefits exist, beneficiaries often do not access them.

Understanding Medicare Advantage

Medicare Advantage, or Medicare Part C, offers private insurance coverage with supplemental benefits such as dental, vision, hearing services, transportation assistance, grocery credits, and fitness programs. Despite these benefits, enrollees face prior authorization requirements and limited provider networks.

The plans attract enrollees with lower or zero-dollar premiums, covering about 55 percent of Medicare beneficiaries. Ryan advises considering doctors, prescriptions, networks, prior authorization, and the ability to change coverage before choosing Medicare Advantage.

Impact of Supplemental Benefits

The study suggests supplemental benefits do not necessarily improve chronic disease outcomes. Previous studies also showed no significant health improvements among seniors with diabetes enrolled in Medicare Advantage.

Financial literacy instructor Alex Beene emphasized that while Medicare Advantage offers additional benefits like food allowances, the access process may involve extensive paperwork.

Kevin Thompson, CEO of 9i Capital Group, warned beneficiaries about the restrictions and barriers associated with Medicare Advantage, such as prior authorizations delaying care access and restricted networks limiting provider choices.

Medicare GLP-1 Bridge Program

The study emerges as newer treatments for chronic diseases become accessible, including GLP-1 medications for diabetes and obesity. The Medicare GLP-1 Bridge Program aims to provide eligible beneficiaries with access to these medications, crucial in managing obesity and related conditions. However, concerns about cost and sustainability remain.

Future Outlook

This study may fuel debate over Medicare Advantage’s effectiveness in delivering health improvements. Spending concerns remain, as federal expenditure per enrollee is higher than in traditional Medicare.

Beene suggests the research is unlikely to lead to immediate changes but may influence beneficiaries’ enrollment decisions.